Even though approximately half a million people die of malaria each year, no approved malaria vaccine that provides sufficient protection exists. Researchers at the Institute for Tropical Medicine in Tübingen have consequently been working to develop such a vaccine for years. They have already succeeded in developing a human infection [...]

There is no effective protective vaccine against malaria available to date. A malaria vaccine would augment current programmes to fight malaria and considerably improve the quality of life in the affected populations. Up to now, the only way of acquiring high-level effective immune protection against malaria is through immunisation with [...]

Malaria continues to account for approximately half a million deaths each year. Children in highly endemic regions in Africa are the most severely affected. To date, an effective vaccine against malaria does not exist. In Tübingen, a vaccination approach which leads to full immunity against malaria parasites has now been [...]

Each year, over 200 million people worldwide contract malaria. The malaria pathogens, called plasmodia, are transmitted by mosquitoes and pass through different stages of development in the liver and red blood cells. Humans develop immunity against the disease after having been routinely exposed to the disease. This immunity is characterised [...]

Advanced chronic kidney disease (CKD) is among the most common chronic health conditions in Germany. CKD 5D patients (CKD stage five with indication for dialysis) have a weakened immune system and are highly susceptible to infections. Pneumococcal pneumonia is one of the most frequent causes of death, even in vaccinated [...]